Identification of Molecular Biomarkers for Cancer Target Therapy Efficacy
- Conditions
- Cancer
- Interventions
- Other: RNA sequencingOther: Transcriptome analysisDrug: palliative careDrug: target drug with the score above 0,1Drug: target drug with the score equal or below 0,1Drug: non-target drug
- First Posted Date
- 2018-10-30
- Last Posted Date
- 2021-09-14
- Lead Sponsor
- OmicsWay Corp.
- Target Recruit Count
- 200
- Registration Number
- NCT03724097
- Locations
- ๐ท๐บ
Kaluga Regional Clinical Oncology Center, Kaluga, Russian Federation
๐บ๐ธOmicsWay Corp., Walnut, California, United States
๐ท๐บOncological Clinical Dispensary No. 1 of the Moscow City Health Department, Moscow, Russian Federation
Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer
- Conditions
- HER2-positive Breast Cancer
- Interventions
- First Posted Date
- 2018-05-11
- Last Posted Date
- 2021-09-14
- Lead Sponsor
- OmicsWay Corp.
- Target Recruit Count
- 40
- Registration Number
- NCT03521245
- Locations
- ๐บ๐ธ
OmicsWay Corp., Walnut, California, United States
๐ท๐บRepublican Oncological Dispensary of the Ministry of Healthcare of Karelia Republic, Petrozavodsk, Karelia Republic, Russian Federation
๐ท๐บ"Oncobox" Ltd., Moscow, Russian Federation
ยฉ Copyright 2025. All Rights Reserved by MedPath